8-K: Gold Flora Reports 13% Sequential Revenue Growth in Q1 2024, Achieves 54% Adjusted Gross Margin

Gold Flora Corporation announced a 13% sequential increase in revenue to $32.2 million and a 54% adjusted gross margin for the first quarter of 2024.

Summary

• Gold Flora Corporation reported its financial results for the first quarter of 2024, showing a 13% sequential increase in total revenue, reaching $32.2 million.
• The company's gross profit was $10.0 million, representing a 31% gross margin, while adjusted gross profit reached $17.4 million, with a 54% adjusted gross margin.
• The company experienced a net loss of $13.7 million for the quarter and an adjusted EBITDA of negative $1.8 million.
• Cash used in operating activities improved by 31.3% sequentially, decreasing to $4.4 million from $6.4 million in the previous quarter.
• As of March 31, 2024, the company held $14.2 million in cash and cash equivalents.
• Gold Flora launched its new brand, Gramlin, in late Q1 2024, which has seen strong initial success.
• The company expanded its cultivation footprint to 160,000 square feet and expects increased volume and margin in the second half of 2024.
• Live rosin products are expected to be introduced in the third quarter of 2024.

Sentiment

Score: 6

Explanation: The sentiment is moderately positive due to strong revenue growth and adjusted gross margin, but tempered by the net loss and negative adjusted EBITDA. The company is showing progress but still has challenges to overcome.

Positives

• The company achieved a 13% sequential increase in total revenue, reaching $32.2 million.
• Adjusted gross margin was a strong 54%, indicating efficient operations.
• Cash used in operating activities improved significantly, decreasing by 31.3% sequentially.
• The successful launch of the Gramlin brand demonstrates the company's ability to identify and capitalize on market opportunities.
• Expansion of the cultivation footprint to 160,000 square feet is expected to increase production volume and margins.
• The company's vertical integration allows it to capture margin at every step of the supply chain.

Negatives

• The company reported a net loss of $13.7 million for the quarter.
• Adjusted EBITDA was negative $1.8 million.
• Gross profit decreased by 24% compared to the previous quarter.
• The company incurred additional costs to expand cultivation, which compressed the realized Q1 2024 gross margin.

Risks

• The company is currently operating at a net loss, which may raise concerns about its financial sustainability.
• The negative adjusted EBITDA indicates that the company is not yet profitable on an operational basis.
• The cannabis industry is subject to regulatory risks and market fluctuations, which could impact the company's performance.
• The company's ability to realize efficiencies from its cultivation expansion over time is not guaranteed.

Future Outlook

The company anticipates seeing the benefits of its scaled operations throughout the remainder of 2024, with future revenue expected to have a disproportionately positive impact on the bottom line, putting the company on the path to sustainable positive free cash flow. They also expect increased volume and margin in the second half of 2024 and plan to introduce live rosin products in the third quarter of 2024.

Management Comments

• Our Q1 2024 results reflect the work we have done to scale our operations to leverage the solid foundation we have built and realize the significant benefits of our vertical integration, said Laurie Holcomb, Chief Executive Officer of Gold Flora.
• Our ability to scale and rapidly act on market opportunities is one of our crucial competitive advantages and our latest brand launch, Gramlin, is a tremendous example of its potential.
• Our vertical operations are now fully in motion and with our platform scaling up, we anticipate seeing the benefits throughout the remainder of 2024.

Industry Context

This announcement reflects the ongoing growth and competition within the California cannabis market, where companies are focusing on vertical integration and brand development to capture market share. Gold Flora's focus on in-house cultivation and manufacturing aligns with industry trends towards controlling the supply chain to improve margins and product quality.

Comparison to Industry Standards

• While Gold Flora's 13% sequential revenue growth is positive, it's important to compare this to other vertically integrated cannabis companies in California, such as Cresco Labs or Curaleaf, to gauge its relative performance.
• The 54% adjusted gross margin is a strong indicator of operational efficiency, but it should be benchmarked against industry averages and the performance of similar companies.
• The negative adjusted EBITDA suggests that the company is still in a growth phase and needs to improve profitability, which is a common challenge for cannabis companies in the early stages of expansion.
• The expansion of cultivation space to 160,000 square feet is a significant step, but its impact on production and profitability will need to be monitored against industry benchmarks for yield and cost per square foot.

Stakeholder Impact

• Shareholders may be concerned about the net loss and negative adjusted EBITDA, but encouraged by the revenue growth and margin improvements.
• Employees may benefit from the company's growth and expansion.
• Customers will have access to new products, such as the Gramlin brand and live rosin products.
• Suppliers may see increased demand for their products as the company expands its operations.
• Creditors will be monitoring the company's financial performance and ability to repay debts.

Next Steps

• The company will focus on post-harvest production to convert high-quality flower into high-margin products.
• They will continue refining genetics and growing methods for profitability and productivity.
• The company plans to introduce live rosin products in the third quarter of 2024.
• They will continue to scale operations and leverage their vertical integration.

Key Dates

Keywords

cannabis, vertical integration, cultivation, distribution, retail, financial results, revenue, gross margin, EBITDA, Gramlin, live rosin